The fusion-active HIV-1 gp41 core structure is a stable sixhelix bundle (6-HB) formed by its N-and C-terminal heptadrepeat sequences (NHR and CHR). A highly conserved, deep hydrophobic cavity on the surface of the N-helical trimer is important for stability of the 6-HB and serves as an ideal target for developing anti-human immunodeficiency virus (HIV) fusion inhibitors. We have recently identified several small molecule HIV-1 fusion inhibitors that bind to the gp41 cavity through hydrophobic and ionic interactions and block the gp41 6-HB formation. Molecular docking analysis reveals that these small molecules fit inside the hydrophobic cavity and interact with positively charged residue Lys 574 to form a conserved salt bridge. In this study, the functionality of Lys 574 has been finely characterized by mutational analysis and biophysical approaches. We found that substitutions of Lys 574 with non-conserved residues (K574D, K574E, and K574V) could completely abolish virus infectivity. With a set of wildtype and mutant N36 peptides derived from the NHR sequence as a model, we demonstrated that non-conservative Lys 574 substitutions severely impaired the stability and conformation of 6-HBs as detected by circular dichroism spectroscopy, native polyacrylamide gel electrophoresis, and enzyme-linked immunosorbent assay. The binding affinity of N36 mutants bearing non-conservative Lys 574 substitutions to the peptide C34 derived from the CHR sequence dramatically decreased as measured by isothermal titration calorimetry. These substitutions also significantly reduced the potency of N-peptides to inhibit HIV-1 infection. Collectively, these data suggest that conserved Lys 574 plays a critical role in 6-HB formation and HIV-1 infectivity, and may serve as an important target for designing anti-HIV drugs.
Entry of human immunodeficiency virus type 1 (HIV-1)3 into target cells is mediated by its envelope glycoprotein (Env), a type I transmembrane protein consisting of surface subunit gp120 and non-covalently associated transmembrane subunit gp41 (1). Sequential binding of HIV-1 gp120 to its cell receptor CD4 and a coreceptor (CCR5 or CXCR4) can trigger a series of conformational rearrangements in gp41 to mediate fusion between viral and cellular membranes (2-4). Structurally, the gp41 ectodomain contains the N-terminal heptad-repeat sequence (NHR) and C-terminal heptad-repeat sequence (CHR), which are adjacent to the fusion peptide and the transmembrane segment, respectively (Fig. 1A). Crystallographic analyses demonstrated that the NHR and CHR associate to form a stable six-helix bundle (6-HB), representing a fusionactive gp41 core structure, in which three N-helices form an interior, parallel coiled-coil trimer, whereas three C-helices pack in an oblique, antiparallel manner into the highly conserved, deep hydrophobic cavity on the surface of the N-helical trimer (Fig. 1B) ) penetrate into the cavity causing an extensive interaction with the hydrophobic residues in the cavity. Considerable evidence imply that interheli...